Authors

Latest:

Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas

Neoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.

Randy Sweis, MD

Latest:

Dr. Randy Sweis on Impact of Atezolizumab Approval in Bladder Cancer

Ranee Mehra, MD

Latest:

Dr Mehra on the Implications of the E3311 Trial in HPV+ Oropharynx Cancer

Ranee Mehra, MD, discusses long-term follow-up data from the phase 2 E3311 trial in patients with HPV-associated oropharynx cancer.

Ranjana Advani, MD

Latest:

Dr. Advani Discusses Front-Line Brentuximab

Ranjana Advani, MD, Professor of Medicine and Oncology, Stanford University, discusses the movement of brentuximab vedotin combined with CHOP to the front-line.

Raoul Concepcion, MD

Latest:

Dr. Concepcion on Transition to Value-Based Model in Urology

Raoul Concepcion, MD, director of the Comprehensive Prostate Center, discusses the impending transition to a value-based model in urology.

Raoul S. Concepcion, MD

Latest:

A Call to Educate

Raoul S. Concepcion, MD, calls for increased oncology education and information sharing among the urology community across the globe, as urologists play a critical role in delivering and managing cancer treatment.

Raoul S. Concepcion, MD, Comprehensive Prostate Center in Nashville

Raoul S. Concepcion, MD, FACS

Latest:

Dr. Concepcion on Current Testing Patterns in Urology Practices

Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses current testing patterns in urology practices.

Raoul S. Concepcion, MD, FACS, Comprehensive Prostate Center

Raoul S. Concepcion, MD, FACS, The Comprehensive Prostate Center

Raoul S. Concepcion, MD, FACS, Urology Associates

Raoul S. Concepcion, MD, Urology Associates

Raoul S. Concepcion, MD, Urology Associates, PC

Raoul Tibes, MD, PhD

Latest:

Dr. Raoul Tibes Discusses FLT3 Inhibitors in AML

Raoul Tibes, MD, PhD, Mayo Clinic

Raphael Bueno, MD

Latest:

Dr. Bueno on Gene Expression Signatures for Squamous Cell Lung Carcinoma

Raphael Bueno, MD, chief, Division of Thoracic Surgery co-director, Brigham and Women’s Lung Center, vice chairman of Surgery for Cancer and Translational Research, professor at Harvard Medical School, discusses gene expression signatures for squamous cell lung carcinoma.

Rasheda Persinger, MSN, AGNP-C, AOCNP

Latest:

Closing Thoughts on Evolving Antibody-Drug Conjugate Landscape

The expert panel concludes the program with key takeaways and closing thoughts on the evolving antibody-drug conjugate space.

Rashmi K. Murthy, MD

Latest:

Dr. Murthy on De-Escalation Strategies in HER2-Positive Breast Cancer

Rashmi K. Murthy, MD, assistant professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses de-escalation strategies for patients with HER2-positive breast cancer.

Rashmi K. Murthy, MD, MBE, MD Anderson Cancer Center

Latest:

Expanding Treatment Options for HER2+ Breast Cancer

Rashmi Murthy, MD, MD Anderson Cancer Center